Management of haemophilia patients in the COVID-19 pandemic: Experience in Wuhan and Tianjin, two differently affected cities in China.
Ai ZhangXiaohong SunMan-Chiu PoonAiguo LiuXiaoping LuoLingling ChenQun HuRenchi YangPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)
The COVID-19 pandemic had varying adverse impacts on haemophilia care depending on the local infection incidence. Our experience suggests that haemophilia management strategies in the pandemic need to be established according to the local virus containment/mitigation policies, daily living restrictions and resource availability.
Keyphrases
- coronavirus disease
- end stage renal disease
- healthcare
- ejection fraction
- newly diagnosed
- sars cov
- chronic kidney disease
- public health
- climate change
- physical activity
- palliative care
- peritoneal dialysis
- emergency department
- quality improvement
- patient reported outcomes
- electronic health record
- patient reported
- adverse drug
- drug induced